Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 58,700 shares at $90.63 ($5.3M) on 2023-07-05, disclosed to the SEC on 2023-07-05.
Scheduled sale ($5.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.63 | 21,728 | $2.0M | 37.0% |
| 2 | $90.63 | 21,728 | $2.0M | 37.0% |
| 3 | $91.22 | 7,622 | $695K | 13.0% |
| 4 | $91.22 | 7,622 | $695K | 13.0% |
| Total | $90.78 avg | 58,700 | $5.3M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |